Indication

Myocardial reinfarction prevention

Myocardial reinfarction prevention refers to secondary prevention strategies directed at patients who have previously experienced an acute myocardial infarction to stop or reduce the risk of a recurrent ischemic cardiac event. Read more about Myocardial reinfarction prevention

361 drugs 181 manufacturers

Advertisement

Drugs that treat it

Common Myocardial reinfarction prevention therapies.

Showing 325–333 of 361 drugs

TICAGRELOR

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·MYOCARDIAL REINFARCTION PREVENTION·+4
EXELAN PHARMACE

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
TARO/SUN PHARMA

ASPIRIN EC (aspirin)

LOW DOSE ASPIRIN (81 MG OR LESS)·MYOCARDIAL REINFARCTION PREVENTION·+11
HEB GROCERY COM

TICAGRELOR

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·MYOCARDIAL REINFARCTION PREVENTION·+4
GSMS, INC.

ASPIRIN EC (aspirin)

LOW DOSE ASPIRIN (81 MG OR LESS)·MYOCARDIAL REINFARCTION PREVENTION·+11
AARNA USA INC

TICAGRELOR

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·MYOCARDIAL REINFARCTION PREVENTION·+4
APHENA PHARMA S

ASPIRIN EC (aspirin)

LOW DOSE ASPIRIN (81 MG OR LESS)·MYOCARDIAL REINFARCTION PREVENTION·+11
RISING PHARM

ASPIRIN

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·ACUTE MYOCARDIAL INFARCTION·+16
GEISS, DESTIN &

TICAGRELOR

ANTIPLATELET DRUGS-EXCLUDING ASA 325 MG AND BELOW·MYOCARDIAL REINFARCTION PREVENTION·+4
Mylan Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Myocardial reinfarction prevention preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Myocardial reinfarction prevention.

Myocardial reinfarction prevention refers to secondary prevention strategies directed at patients who have previously experienced an acute myocardial infarction to stop or reduce the risk of a recurrent ischemic cardiac event.

It addresses the cardiovascular system, specifically targeting the coronary vasculature and myocardium in individuals with established coronary artery disease.

Pathophysiologically, these patients carry a heightened risk of subsequent plaque rupture, erosion, coronary thrombosis, and further myocardial necrosis, which can lead to progressive ventricular dysfunction, heart failure, or cardiovascular death.

Clinically, prevention is defined by long-term management aimed at stabilizing atherosclerotic plaques, suppressing platelet aggregation, and mitigating myocardial oxygen demand to prevent re-occlusion and recurrent infarction.

Personalize your experience

Follow Myocardial reinfarction prevention and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it